Interestingly, p53 directly represses the expression of glycolysis genes [75,76], which may in part underlie the selection for loss of p53 function in MYC deregulated cancers that rely heavily on glycolysis for energetic demands and anabolic precursors, including MM. The gene discussed is MYC; the disease is cancer.